Pliva d d
I've been following Pliva in the news for months. Pliva, a pharmaceutical
concern with $1.1 billion in revenues and 6,600 employees, has
been the subject of a takeover battle between two suitors; Barr
Pharmaceuticals (USA) and Actavis Group (Iceland). So, why am
I bothering visiting Pliva since it'll soon be just a subsidiary?
Past experiences. Over the years quite a few companies have been
crossed off my list to be visited after a merger was announced.
However, months later I'd then read where the merger was called
off for one reason or another. So, I've learn that it's not officially
official until all the final documents have been signed and,
the fat lady sings.
Pliva's eight-story headquarters can be found on Ulica Grada
Vukovara, Zagreb's wide thoroughfare that seems to be the location
of choice for businesses. The building's granite façade
looks impressive but the rear of the structure butts up to an
unsightly railroad freight yard. Two receptionist man the reception
counter and before answering any questions they want to see identification
so, I pull out my passport and watch as they copy information
off of it. This identification request must be standard procedure
as it has happened at every company visited in Croatia. I explain
mailing a letter of introduction a month ago to CEO Zeljko Covic
and ask if his secretary can be called to find out where or with
whom my letter ended up with. After making several calls the
receptionist hands over the phone and I talk with a woman in
corporate communications. The woman says she checked around and
no one knows anything about my letter. I ask if someone would
have a few minutes to meet with me but am told it isn't possible.
Jeez, there's something fishy going on here in Zagreb as every
company visited claims to not have received my letter of introduction.
Could this be true or is it the Croatian way things are done?
Company website: www.pliva.com
|